تأثير نبات الكرفس (Apium gravyolens L.) على ذبابة الفاكهة السوداء

Niveditha S, Ramesh SR, Shivanandappa T. Paraquat-induced movement disorder in relation to oxidative stress-mediated neurodegeneration in the brain of Drosophila melanogaster. Neuro Res. 2017; 42: 3310–20. http://doi.org/ 10.1007/s11064-017-2373-y

WHO. Conclusion and recommendations, Neurological Disorders: Public Health Challenges, World Health Organization, (Chapter 4), 2006.

Siddique YH, Jyoti S. Alteration in biochemical parameters in the brain of transgenic Drosophila melanogaster model of Parkinson’s disease exposed to apigenin. Integ Med Res. 2017; 6(3): 245–253. https://doi.org/10.1016/j.imr.2017.04.003

Thakolwiboon S, Julayanont P, Ruthirago D. Pesticides and Parkinson’s disease: A potential hazard in agricultural communities. Southwest Respir. Crit. Care Chron. 2017; 5(20): 60–67. https://doi.org/10.12746/swrccc. v5i20.406

Nagpal I, Abraham SK. Ameliorative effects of gallic acid, quercetin and limonene on urethane-induced genotoxicity and oxidative stress in Drosophila melanogaster. Toxicol Mech Methods. 2017 Feb; (1 – 8). https://doi.org/10.1080/15376516.2016.1278294

Jhonsa DJ, Badgujar LB, Sutariya BK, Saraf MN. Neuroprotective effect of flavonoids against paraquat induced oxidative stress and neurotoxicity in Drosophila melanogaster. Curr Top Nutraceutical Res. 2016; 14 (4): 283-294.

Sanz FJ, Solana-Manrique C, Muñoz-Soriano V, Calap-Quintana P, Moltó MD, Paricio N. Identification of potential therapeutic compounds for Parkinson's disease using Drosophila and human cell models. Free Rad Bio Med. 2017 Apr; 108: 683–691. https://doi.org/10.1016/j.freeradbiomed.2017.04.364

Stephano F, Nolte S, Hoffmann J, El-Kholy S, von Frieling J, Bruchhaus I, et al. Impaired Wnt signaling in dopamine containing neurons is associated with pathogenesis in a rotenone triggered Drosophila Parkinson’s disease model. Sci Report. 2018; 8: 2372. https://doi.org/10.1038/s41598-018-20836-w

Yang SY, Gegg M, Chau D, Schapira A. Glucocerebrosidase activity, cathepsin D and monomeric α-synuclein interactions in a stem cell derived neuronal model of a PD associated GBA1 mutation. Neurobiol Dis. 2020 Feb; 134 :1-8. https://doi.org/10.1016/j.nbd.2019.104620

Xiong Y, Yu J. Modeling Parkinson’s Disease in Drosophila: What Have We Learned for Dominant Traits? Front. Neurol. 2018 Apr; 9 (228): 1-15. https://doi.org/10.3389/fneur.2018.00228

Sakai R, Suzuki M, Ueyama M, Takeuchi T, Minakawa EN, Hayakawa H, et al. E46K mutant α-synuclein is more degradation resistant and exhibits greater toxic effects than wild-type α-synuclein in Drosophila models of Parkinson's disease. PLoS One. 2019 Jun 26; 14(6): e0218261. https://doi.org/10.1371/journal.pone.0218261

Soares J J, Rodrigues DT, Gonçalves MB, Lemos MC, Gallarreta MS, Bianchini MC, et al. Paraquat exposure-induced Parkinson’s disease-like symptoms and oxidative stress in Drosophila melanogaster: Neuroprotective effect of Bougainvillea glabra Choisy, Biomed Pharmacother. 2017; 95: 245–251. https://doi.org/10.1016/j.biopha.2017.08.073

Aryal B, Lee Y. Disease model organism for Parkinson disease: Drosophila melanogaster. BMB Rep. 2019 Nov; 52(4): 250-258. https://doi.org/10.5483/BMBRep.2019.52.4.204

Helena Xicoy H, Peñuelas N, Miquel Vila M, Laguna A. Autophagic- and Lysosomal-Related Biomarkers for Parkinson’s Disease: Lights and Shadows. Cells. 2019 Oct; 8 (1317): 1-20. https://doi.org/10.3390/cells8111317

Xiong Y, Dawson, TM, Dawson VL. Models of LRRK2 associated Parkinson’s disease. Adv Neurobiol. 2017 Jan; 14: 163–191. https://doi.org/10.1007/978-3-319-49969-7_9.

Quintero-Espinosa D, Jimenez-Del-Rio M, Velez-Pardo C. Knockdown transgenic Lrrk Drosophila resists paraquat-induced locomotor impairment and neurodegeneration: A therapeutic strategy for Parkinson’s disease, Brain Res. 2016; 1657: 253-261. https://doi.org/10.1016/j.brainres.2016.12.023

Tapias V. Editorial: Mitochondrial Dysfunction and Neurodegeneration. Front Neurosci. 2019 Dec; 13 (1372): 1-4. https://doi.org/10.3389/fnins.2019.01372

Rzezniczak TZ, Douglas LA, Watterson JH, Merritt TJS. Paraquat administration in Drosophila for use in metabolic studies of oxidative stress. Anal Biochem. 2017; 419(2): 345–347. https://doi.org/10.1016/j.ab.2011.08.023

Stockum SV, Sanchez-Martinez A, Corra S. Inhibition of the deubiquitinase USP8 corrects a Drosophila PINK1 model of mitochondria dysfunction. Life sci alliance. 2019 Apr; 2(2): 1-16. https://doi.org/10.26508/lsa.201900392

McCann ME, de Graaff JC, Dorris L. Neurodevelopmental outcome at 5 years of age after general anaesthesia or awake-regional anaesthesia in infancy (GAS): an international, multicentre, randomised, controlled equivalence trial. Lancet. 2019 Feb; 393: 664–77. https://doi.org/10.1016/S0140-6736(18)32485-1

Nelson MP, Boutin M, Tonia ET, Lu H, Haley ED, Ouyang X, et al. The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson’s disease brain in association with the pathologic accumulation of alpha-synuclein. Neurobiol Dis . 2018 Feb; 110: 68–81. https://doi.org/10.1016/j.nbd.2017.11.006

Wells C, Brennan SE, Keon M, Saksena NK. Prionoid Proteins in the Pathogenesis of Neurodegenerative Diseases. Front. Mol. Neurosci. 2019 Nov; 12 (271): 1-24. https://doi.org/10.3389/fnmol.2019.00271

Lazzari FD, Sandrelli F, Whitworth AJ, Bisaglia M. Antioxidant Therapy in Parkinson’s Disease: Insights from Drosophila melanogaster. Antioxidants. 2020; 9 (52): 1-17. https://doi.org/10.3390/antiox9010052